KPL
NSEKwality Pharmaceuticals Limited (SMALL CAP)
Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹2,492.60
130.20 (5.51%)
High VOLATILITY
As on 12 Jun 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹2.59K Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
N/A
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹1,561+59.7%
52W High₹2,600-4.1%
Current Price
₹2,492.60
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹1,994.08
Upper Circuit₹2,991.12
Reference Price
₹2,492.60
Investment Checklist
Trend: Price above all key MAs — strong uptrend
Volume divergence: Bearish (price up, volume down)
SuperTrend(10,3): Price above SuperTrend (Industry Standard (Swing/Medium-Term))
SuperTrend(7,3): Price above SuperTrend (Responsive Setting (Day Trading/Short-Term))
3-day momentum: +6.6% — strong upward pressure
Technical Analysis
Technical Analysis
Analysis from 2026-06-12
Confidence
75%
Trend
BULLISH
BULLISH
Price above all key MAs — strong uptrend
EMA20
2219.1
Price Action
MIXED
NEUTRAL
Higher Highs6
Higher Lows5
Lower Highs3
Lower Lows4
Support & Resistance Levels
Resistance (Above)
No recent resistance detected
Support (Below)
₹1769.00
₹1564.00
Volume Analysis
TrendDECREASING
Change-61.10%
Unusual VolumeNo
Divergence Detected
Bearish (price up, volume down)
Stop Loss Levels
Fixed Risk
1% Risk₹2467.67
3% Risk₹2417.82
5% Risk₹2367.97
7% Risk (Custom)
₹2318.12Technical Levels
1x ATR (Volatility)₹2347.67
2x ATR (Swing)₹2202.74
3x ATR (Trend)₹2057.81
Immediate Support₹1769.00
Moving Averages
EMA 9 (Short-term)₹2365.20
EMA 20 (Medium-term)₹2219.10
Financials
Financial data not available
Peer Comparison
PharmaceuticalsPeer Comparison
| Symbol | Name | Price | Change |
|---|---|---|---|
| SUNPHARMA | Sun Pharmaceutical Industries Limited | ₹1,807.70 | +0.75% |
| DIVISLAB | Divi's Laboratories Limited | ₹6,638.00 | -0.26% |
| TORNTPHARM | Torrent Pharmaceuticals Limited | ₹4,571.20 | -0.02% |
| CIPLA | Cipla Limited | ₹1,389.40 | +0.44% |
| ZYDUSLIFE | Zydus Lifesciences Limited | ₹1,104.70 | -0.11% |
| DRREDDY | Dr. Reddy's Laboratories Limited | ₹1,275.40 | -0.05% |
| LUPIN | Lupin Limited | ₹2,293.30 | +0.88% |
| MANKIND | Mankind Pharma Limited | ₹2,381.10 | +0.35% |
| AUROPHARMA | Aurobindo Pharma Limited | ₹1,472.80 | +0.59% |
| LAURUSLABS | Laurus Labs Limited | ₹1,394.30 | +0.25% |
Corporate Information
Latest News
News for KPL
View All
positive
Business Standard - Markets 24d ago
Kwality Pharmaceuticals shares jump 10% to hit 52-week high on Q4 results
Management said there remains potential upside to the guidance, depending on the pace of approvals, registrations, and commercialisation across key international markets
KPLHealthcare
NEWS
positive
Business Standard - Markets 25d ago
Kwality Pharma surges on strong Q4 numbers; PAT jumps 75%
Kwality Pharmaceuticals rose 9.06% to Rs 2,000 after the company reported strong earnings growth for the quarter ended March 2026.
KPLHealthcare
NEWS
positive
Business Standard - Markets 25d ago
Kwality Pharmaceuticals consolidated net profit rises 74.60% in the March 2026 quarter
Sales rise 35.81% to Rs 157.11 crore
KPLHealthcare